VENOUS THROMBOEMBOLISM MARKET ANALYSIS

Regional Analysis

Global venous thromboembolism market regional overview

Based on the article published by the steering committee of world Thrombosis Day in 2014, incidence rate of VTE in North America, Western Europe, Australia and southern Latin America (Argentina) was in the range of 0.75-2.69 per 1,000 individuals, which increase to 2-7 per 1,000 individuals in population aged 70 years and above. Moreover, according to its research findings, awareness about venous thromboembolism is very low globally. Furthermore, the condition is largely undocumented, except in North America and Europe. Daiichi Sankyo Company, Limited commenced a large scale clinical registry for cancer-VTE patients in Japan, in March 2017. This facility would enroll and follow up to 10,000 cancer patients for a year to achieve following objectives:

• Frequency of concurrent VTE
• Treatment status of VTE
• Investigate the incidence of VTE events, ischemic stroke, hemorrhagic events, and systemic embolisms
• Clarify appropriate use of Direct Oral Anticoagulant (DOAC) including Lixiana (Edoxaban)